Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Alexandrosz Czira, Shoko Akiyama, Takeo Ishii, Robert P Wood, Lucinda J Camidge, Hannah Wallis, Thomas Jennison, Rosie AC Wild, Masao Yarita, Kenichi Hashimoto, Kieran J Rothnie & Afisi S Ismaila. (2023) Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2933-2953.
Read now
Read now
Xue-Qing Yu, Jia-Qi Di, Wei Zhang, Geng-Shu Wei, Zhan-Ping Ma, Lei Wu, Xue-Feng Yu, Hui-Zhi Zhu, Miao Zhou, Cui-Ling Feng, Ji-Hong Feng, Ping Fan, Jian-Sheng Li & Jian-Ya Yang. (2023) Bu-Fei Yi-Shen Granules Reduce Acute Exacerbations in Patients with GOLD 3–4 COPD: A Randomized Controlled Trial. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2439-2456.
Read now
Read now
Wenwen Wang, Aihua Mei, Hang Qian, Dongfeng Li, Hao Xu, Jishun Chen, Handong Yang, Xinwen Min, Chunlei Li, Li Cheng & Jun Chen. (2023) The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 129-137.
Read now
Read now
Guohuan Chen, Qingyu Lin, Debin Zhuo & Jinhe Cui. (2022) Elevated Blood Glucose is Associated with Severe Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2453-2459.
Read now
Read now
Yong Suk Jo, Sung Kyoung Kim, Seoung Ju Park, Soo-Jung Um, Yong-Bum Park, Ki Suck Jung, Deog Kyeom Kim & Kwang Ha Yoo. (2019) Longitudinal change of FEV1 and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 361-369.
Read now
Read now
Stéphanie Cousse, André Gillibert, Mathieu Salaün, Luc Thiberville, Antoine Cuvelier & Maxime Patout. (2019) Efficacy of a home discharge care bundle after acute exacerbation of COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 289-296.
Read now
Read now
João Cardoso, Ricardo Coelho, Carla Rocha, Constança Coelho, Luísa Semedo & A Bugalho Almeida. (2018) Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1105-1113.
Read now
Read now
Alain Vanasse, Josiane Courteau, Simon Couillard, Marie-France Beauchesne & Pierre Larivée. (2017) Predicting One-year Mortality After a “First” Hospitalization for Chronic Obstructive Pulmonary Disease: An Eight-Variable Assessment Score Tool. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:5, pages 490-497.
Read now
Read now
Chih-Jen Yang, Wen-I Liao, Zun-Cheng Tang, Jen-Chun Wang, Chien-Hsing Lee, Wei-Chou Chang, Chin-Wang Hsu, Shih-En Tang & Shih-Hung Tsai. (2017) Glycated hemoglobin A1c-based adjusted glycemic variables in patients with diabetes presenting with acute exacerbation of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1923-1932.
Read now
Read now
Articles from other publishers (34)
Nooshin Hemmati, Gholamreza Mortazavi Moghaddam, Fatemeh Salmani & Mahmood Zardast. (2023) Predictors of In-hospital Outcomes in Hospitalized Patients With COPD Exacerbation. Zahedan Journal of Research in Medical Sciences 25:2.
Crossref
Crossref
Carmen Reumkens, Adrian Endres, Sami O. Simons, Paul H.M. Savelkoul, Roy T.M. Sprooten & Frits M.E. Franssen. (2023) Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients. ERJ Open Research 9:3, pages 00569-2022.
Crossref
Crossref
Stanislav Kotlyarov. (2023) The Role of Multidimensional Indices for Mortality Prediction in Chronic Obstructive Pulmonary Disease. Diagnostics 13:7, pages 1344.
Crossref
Crossref
Qing Song, Ling Lin, Wei Cheng, Xue-Shan Li, Yu-Qin Zeng, Cong Liu, Min-Hua Deng, Dan Liu, Zhi-Ping Yu, Xin Li, Li-Bing Ma, Yan Chen, Shan Cai & Ping Chen. (2023) Clinical–functional characteristics and risk of exacerbation and mortality among more symptomatic patients with chronic obstructive pulmonary disease: a retrospective cohort study. BMJ Open 13:3, pages e065625.
Crossref
Crossref
Inna Antonova, Oleksiy Gridnyev & Valentina Galchinskaya. (2022) EPOXID HYDROLASE SINGLE GENE POLYMORPHISM (RS1051740) AND SEVERITY OF CHRONIC OBSTRUCTIVE DISEASE. Wiadomości Lekarskie 75:11, pages 2779-2784.
Crossref
Crossref
Behrang Motamed, Ali Alavi Foumani, Azita Tangestaninezhad, Mohammad Almasi, Niloofar Faraji & Alireza Jafarinezhad. (2022) The relationship between glycated hemoglobin A1c levels and exacerbation status in the patients with chronic obstructive pulmonary disease. BMC Research Notes 15:1.
Crossref
Crossref
Dong Huang, Dingxiu He, Linjing Gong, Rong Yao, Wen Wang, Lei Yang, Zhongwei Zhang, Qiao He, Zhenru Wu, Yujun Shi & Zongan Liang. (2022) A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease. Respiratory Research 23:1.
Crossref
Crossref
Alexander J Davies, Paul W Blessing & Wesley P Eilbert. (2022) Measurement of Procalcitonin as an Indicator of Severity in Patients With Chronic Obstructive Pulmonary Disease Admitted With Respiratory Illness. Cureus.
Crossref
Crossref
William T. Crawley, Cyprien G. Jungels, Kurt R. Stenmark & Mehdi A. Fini. (2022) U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia. Redox Biology 51, pages 102271.
Crossref
Crossref
Yahong Chen, Jing Zhang & Jeffrey L. Curtis. (2022) Editorial: Toolkits for Prediction and Early Detection of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Frontiers in Medicine 9.
Crossref
Crossref
Zixiong Zeng, Qin Liu, Xiaoying Huang, Chunyan Lu, Juan Cheng, Yuqun Li, Guoping Hu & Liping Wei. (2022) Prognostic Role of Chronic Obstructive Pulmonary Disease and Asthma Physiology Score for in-Hospital and 1-year Mortality in Patients with Acute Exacerbations of COPD. Canadian Respiratory Journal 2022, pages 1-9.
Crossref
Crossref
Niamh Kelly, Lewis Winning, Christopher Irwin, Fionnuala T. Lundy, Dermot Linden, Lorcan McGarvey, Gerard J. Linden & Ikhlas A. El Karim. (2021) Periodontal status and chronic obstructive pulmonary disease (COPD) exacerbations: a systematic review. BMC Oral Health 21:1.
Crossref
Crossref
Xiaobo Li, Guangyu Zhou, Xiaobo Tian, Fei Chen, Guoyao Li & Yipeng Ding. (2021) The polymorphisms of FGFR2 and MGAT5 affect the susceptibility to COPD in the Chinese people. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Li Lin, Jianxin Shi, Jian Kang & Qiuyue Wang. (2021) Analysis of prevalence and prognosis of type 2 diabetes mellitus in patients with acute exacerbation of COPD. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Akihiro Shiroshita, Chisato Miyakoshi, Shunta Tsutsumi, Hiroshi Shiba, Chigusa Shirakawa, Kenya Sato, Shinya Matsushita, Yuya Kimura, Keisuke Tomii, Masahiro Ohgiya & Yuki Kataoka. (2021) Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study. Scientific Reports 11:1.
Crossref
Crossref
David Carballo, Nicolas Garin, Jérôme Stirnemann, Aline Mamin, Virginie Prendki, Philippe Meyer, Christophe Marti, Francois Mach, Jean-Luc Reny, Jacques Serratrice, Laurent Kaiser & Sebastian Carballo. (2021) Prognosis of Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in Acute Heart Failure. Journal of Clinical Medicine 10:19, pages 4546.
Crossref
Crossref
Pin-Kuei Fu, Yu-Feng Wei, Chau-Chyun Sheu, Chen-Yu Wang, Chi-Kuei Hsu, Chia-Min Chen, Wei-Chih Chen & Kuang-Yao Yang. (2020) Effect of Tiotropium Soft Mist Inhalers on Dynamic Changes in Lung Mechanics of Patients with Chronic Obstructive Pulmonary Disease Receiving Mechanical Ventilation: A Prospective Pilot Study. Pharmaceutics 13:1, pages 51.
Crossref
Crossref
Elizabeth G. Bond, Lusine Abrahamyan, Mohammad K. A. Khan, Andrea Gershon, Murray Krahn, Ping Li, Rajibul Mian, Nicholas Mitsakakis, Mohsen Sadatsafavi, Teresa To & Petros Pechlivanoglou. (2020) Understanding resource utilization and mortality in COPD to support policy making: A microsimulation study. PLOS ONE 15:8, pages e0236559.
Crossref
Crossref
Corrie Farris. (2020) Prognostic Tools in Hospice and Palliative Medicine. Physician Assistant Clinics 5:3, pages 331-340.
Crossref
Crossref
Nithyananda Thorenoor, Yuka Imamura Kawasawa, Chintan K. Gandhi & Joanna Floros. (2020) Sex-Specific Regulation of Gene Expression Networks by Surfactant Protein A (SP-A) Variants in Alveolar Macrophages in Response to Klebsiella pneumoniae. Frontiers in Immunology 11.
Crossref
Crossref
Sebastian Carballo, Jérôme Stirnemann, Nicolas Garin, Pauline Darbellay Farhoumand, Jacques Serratrice & David Carballo. (2020) Prognosis of patients eligible for dapagliflozin in acute heart failure. European Journal of Clinical Investigation 50:6.
Crossref
Crossref
Chen Gong, Ying Yang, Minli Chen & Zhengfu Xie. (2020) Effect of procalcitonin on the prognosis of patients with COPD. Biomedical Reports.
Crossref
Crossref
Jun-Jun Yeh, Cheng-Li Lin & Chia-Hung Kao. (2020) Associations among chronic obstructive pulmonary disease with asthma, pneumonia, and corticosteroid use in the general population. PLOS ONE 15:2, pages e0229484.
Crossref
Crossref
María-Teresa García-Sanz, Sandra Martínez-Gestoso, Uxío Calvo-Álvarez, Liliana Doval-Oubiña, Sandra Camba-Matos, Carlos Rábade-Castedo, Carlota Rodríguez-García & Francisco-Javier González-Barcala. (2020) Impact of Hyponatremia on COPD Exacerbation Prognosis. Journal of Clinical Medicine 9:2, pages 503.
Crossref
Crossref
Timothy Capecchi & Andrew PJ Olson. (2019) Breathing New Life Into Vital Sign Measurement. Journal of Hospital Medicine 14:11, pages 719-720.
Crossref
Crossref
Mi Zhou, Chuan Chen, Junfeng Peng, Ching-Hsing Luo, Ding Yun Feng, Hailing Yang, Xiaohua Xie & Yuqi Zhou. (2019) Fast Prediction of Deterioration and Death Risk in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Using Vital Signs and Admission History: Retrospective Cohort Study. JMIR Medical Informatics 7:4, pages e13085.
Crossref
Crossref
Izabela Zakowska, Katarzyna Kosiek, Anna Kowalczyk, Jacek Grabowski & Maciek Godycki-Cwirko. (2019) Community determinants of COPD exacerbations in elderly patients in Poland: protocol for a retrospective Big Data observational cohort study. BMJ Open 9:6, pages e030524.
Crossref
Crossref
Mohsen Sadatsafavi, Shahzad Ghanbarian, Amin Adibi, Kate Johnson, J. Mark FitzGerald, William Flanagan, Stirling Bryan & Don Sin. (2019) Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada. Medical Decision Making 39:2, pages 152-167.
Crossref
Crossref
Nadim Akasheh, Declan Byrne, Peter Coss, Richard Conway, Seán Cournane, Deirdre O'Riordan & Bernard Silke. (2019) Lung function and outcomes in emergency medical admissions. European Journal of Internal Medicine 59, pages 34-38.
Crossref
Crossref
Hongyan Pang, Lei Wang, Jie Liu, Shengfeng Wang, Yuanhua Yang, Ting Yang & Chen Wang. (2018) The prevalence and risk factors of venous thromboembolism in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease. The Clinical Respiratory Journal 12:11, pages 2573-2580.
Crossref
Crossref
Robert M. Burkes, Amanda J. Gassett, Agathe S. Ceppe, Wayne Anderson, Wanda K. O’Neal, Prescott G. Woodruff, Jerry A. Krishnan, R. Graham Barr, MeiLan K. Han, Fernando J. Martinez, Alejandro P. Comellas, Allison A. Lambert, Joel D. Kaufman, Mark T. Dransfield, J. Michael Wells, Richard E. Kanner, Robert PaineIIIIII, Eugene R. Bleecker, Laura M. Paulin, Nadia N. Hansel, M. Bradley Drummond, Neil E. Alexis, Wayne H. Anderson, R. Graham Barr, Eugene R. Bleecker, Richard C. Boucher, Russell P. Bowler, Elizabeth E. Carretta, Stephanie A. Christenson, Alejandro P. Comellas, Christopher B. Cooper, David J. Couper, Gerard J. Criner, Ronald G. Crystal, Jeffrey L. Curtis, Claire M. Doerschuk, Mark T. Dransfield, Christine M. Freeman, MeiLan K. Han, Nadia N. Hansel, Annette T. Hastie, Eric A. Hoffman, Robert J. Kaner, Richard E. Kanner, Eric C. Kleerup, Jerry A. Krishnan, Lisa M. LaVange, Stephen C. Lazarus, Fernando J. Martinez, Deborah A. Meyers, Wendy C. Moore, John D. Newell, Laura Paulin, Stephen Peters, Elizabeth C. Oelsner, Wanda K. O’Neal, Victor E. Ortega, Robert Paine, Nirupama Putcha, Stephen I. Rennard, Donald P. Tashkin, Mary Beth Scholand, J. Michael Wells, Robert A. Wise, Prescott G. Woodruff, Lisa Postow & Thomas Croxton. (2018) Rural Residence and Chronic Obstructive Pulmonary Disease Exacerbations. Analysis of the SPIROMICS Cohort. Annals of the American Thoracic Society 15:7, pages 808-816.
Crossref
Crossref
Pauline V. van Hirtum, Roy T.M. Sprooten, Jan A. van Noord, Monique van Vliet & Martijn D. de Kruif. (2018) Long term survival after admission for COPD exacerbation: A comparison with the general population. Respiratory Medicine 137, pages 77-82.
Crossref
Crossref
Patrick Chow Yuen Ng, Brit Long & Alex Koyfman. (2018) Clinical chameleons: an emergency medicine focused review of carbon monoxide poisoning. Internal and Emergency Medicine 13:2, pages 223-229.
Crossref
Crossref
Maria-Teresa Garcia-Sanz. (2017) Identifying prognostic factors in chronic obstructive pulmonary disease patients. Lung India 34:6, pages 497.
Crossref
Crossref